Attention Deficit Hyperactivity Disorder (ADHD) Industry Research Report 2023

Attention Deficit Hyperactivity Disorder (ADHD) Industry Research Report 2023


Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

Highlights

The global Attention Deficit Hyperactivity Disorder (ADHD) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

There are two main types of drugs used to treat ADHD: stimulants and non-stimulants

The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.

ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%

Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder (ADHD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder (ADHD).

The Attention Deficit Hyperactivity Disorder (ADHD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Attention Deficit Hyperactivity Disorder (ADHD) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Attention Deficit Hyperactivity Disorder (ADHD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH

Product Type Insights

Global markets are presented by Attention Deficit Hyperactivity Disorder (ADHD) type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Attention Deficit Hyperactivity Disorder (ADHD) are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Attention Deficit Hyperactivity Disorder (ADHD) segment by Type
Stimulant
Non-stimulant

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Attention Deficit Hyperactivity Disorder (ADHD) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Attention Deficit Hyperactivity Disorder (ADHD) market.

Attention Deficit Hyperactivity Disorder (ADHD) Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Attention Deficit Hyperactivity Disorder (ADHD) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Attention Deficit Hyperactivity Disorder (ADHD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Attention Deficit Hyperactivity Disorder (ADHD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Attention Deficit Hyperactivity Disorder (ADHD) industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Attention Deficit Hyperactivity Disorder (ADHD).

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Attention Deficit Hyperactivity Disorder (ADHD) by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Stimulant
1.2.3 Non-stimulant
2.3 Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel
2.3.1 Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029)
2.3.2 Hospital Pharmacy
2.3.3 Retail Pharmacy
2.4 Assumptions and Limitations
3 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Type
3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2018-2023)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2023-2028)
4 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Distribution Channel
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Distribution Channel (2018-2023)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2018-2023)
5 Global Growth Trends
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2018-2029)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region
5.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Region (2018-2023)
5.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2024-2029)
5.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics
5.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends
5.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
5.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
5.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue
6.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (2018-2023)
6.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2018-2023)
6.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Head office and Area Served
6.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Players, Product Type & Application
6.5 Global Attention Deficit Hyperactivity Disorder (ADHD) Players, Date of Enter into This Industry
6.6 Global Attention Deficit Hyperactivity Disorder (ADHD) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)
7.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)
7.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)
8.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)
8.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)
9.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)
9.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)
10.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)
10.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)
11.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)
11.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma
11.5.1 Tris Pharma Company Detail
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.5.5 Tris Pharma Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Detail
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Detail
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Detail
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Detail
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Detail
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.10.5 Purdue Parma Recent Development
11.11 CTFH
11.11.1 CTFH Company Detail
11.11.2 CTFH Business Overview
11.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.11.4 CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022)
11.11.5 CTFH Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2018-2023)
Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2024-2029)
Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2018-2023)
Table 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2024-2029)
Table 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2018-2023)
Table 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2024-2029)
Table 18. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends
Table 19. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
Table 20. Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
Table 21. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
Table 22. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Headquarters and Area Served
Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)
Table 45. Takeda Company Detail
Table 46. Takeda Business Overview
Table 47. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 48. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 49. Takeda Recent Development
Table 50. Johnson & Johnson Company Detail
Table 51. Johnson & Johnson Business Overview
Table 52. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 53. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 54. Johnson & Johnson Recent Development
Table 55. Novartis Company Detail
Table 56. Novartis Business Overview
Table 57. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 58. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. Eli Lilly Company Detail
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 63. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 64. Eli Lilly Recent Development
Table 65. Tris Pharma Company Detail
Table 66. Tris Pharma Business Overview
Table 67. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 68. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 69. Tris Pharma Recent Development
Table 70. Neos Therapeutics Company Detail
Table 71. Neos Therapeutics Business Overview
Table 72. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 73. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 74. Neos Therapeutics Recent Development
Table 75. Mallinckrodt Company Detail
Table 76. Mallinckrodt Business Overview
Table 77. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 78. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 79. Mallinckrodt Recent Development
Table 80. Amneal Pharmaceuticals Company Detail
Table 81. Amneal Pharmaceuticals Business Overview
Table 82. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 83. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 84. Amneal Pharmaceuticals Recent Development
Table 85. Noven Pharmaceuticals Company Detail
Table 86. Noven Pharmaceuticals Business Overview
Table 87. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 88. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 89. Noven Pharmaceuticals Recent Development
Table 90. Purdue Parma Company Detail
Table 91. Purdue Parma Business Overview
Table 92. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product
Table 93. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 94. Purdue Parma Recent Development
Table 95. CTFH Company Detail
Table 96. CTFH Business Overview
Table 97. CTFH Attention Deficit Hyperactivity Disorder (ADHD)Product
Table 98. CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2017-2022) & (US$ Million)
Table 99. CTFH Recent Development
Table 100. Takeda Company Information
Table 101. Takeda Business Overview
Table 102. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 103. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 104. Takeda Recent Development
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 108. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 109. Johnson & Johnson Recent Development
Table 110. Novartis Company Information
Table 111. Novartis Business Overview
Table 112. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 113. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 114. Novartis Recent Development
Table 115. Eli Lilly Company Information
Table 116. Eli Lilly Business Overview
Table 117. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 118. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 119. Eli Lilly Recent Development
Table 120. Tris Pharma Company Information
Table 121. Tris Pharma Business Overview
Table 122. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 123. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 124. Tris Pharma Recent Development
Table 125. Neos Therapeutics Company Information
Table 126. Neos Therapeutics Business Overview
Table 127. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 128. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 129. Neos Therapeutics Recent Development
Table 130. Mallinckrodt Company Information
Table 131. Mallinckrodt Business Overview
Table 132. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 133. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 134. Mallinckrodt Recent Development
Table 135. Amneal Pharmaceuticals Company Information
Table 136. Amneal Pharmaceuticals Business Overview
Table 137. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 138. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 139. Amneal Pharmaceuticals Recent Development
Table 140. Noven Pharmaceuticals Company Information
Table 141. Noven Pharmaceuticals Business Overview
Table 142. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 143. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 144. Noven Pharmaceuticals Recent Development
Table 145. Purdue Parma Company Information
Table 146. Purdue Parma Business Overview
Table 147. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 148. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 149. Purdue Parma Recent Development
Table 150. CTFH Company Information
Table 151. CTFH Business Overview
Table 152. CTFH Attention Deficit Hyperactivity Disorder (ADHD)Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)
Table 153. CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million) Portfolio
Table 154. CTFH Recent Development
Table 155. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Attention Deficit Hyperactivity Disorder (ADHD) Product Picture
Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type: 2022 VS 2029
Figure 7. Stimulant Product Picture
Figure 8. Non-stimulant Product Picture
Figure 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2023-2029) & (US$ Million)
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel: 2022 VS 2029
Figure 11. Hospital Pharmacy Product Picture
Figure 12. Retail Pharmacy Product Picture
Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region: 2022 VS 2029
Figure 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players in 2022
Figure 17. Global Attention Deficit Hyperactivity Disorder (ADHD) Players, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share by Revenue in 2022
Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)
Figure 22. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)
Figure 26. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)
Figure 34. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)
Figure 42. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)
Figure 46. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. UAE Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 52. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 53. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 54. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 55. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 56. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 57. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 58. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)
Figure 59. CTFH Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings